These lists are based on average ratings* received in 2019 on the
AskaPatient web site. Average ratings listed are for 2019 only, so overall drug
rating may be higher or lower.
Links to Top Rated Drugs of 2019
Rating | Drug | Common Use: |
4.0 | WELLBUTRIN | depression |
3.9 | COMBIPATCH | hot flashes |
3.5 | ZOLOFT | depression |
3.4 | LAMICTAL | bipolar; seizures |
3.3 | CIALIS (tie) | erectile dysfunction |
3.3 | CHANTIX (tie) | quit smoking |
Links to Worst Rated Drugs of 2019
Rating | Drug | Common Use: |
1.0 | DEPO MEDROL | pain |
1.1 | LIPITOR (tie) | high cholesterol |
1.1 | PROLIA (tie) | osteoporosis |
1.14 | CLINDAMYCIN HCL |
antibiotic |
1.15 | ROGAINE EXTRA STRENGTH (FOR MEN) |
hair loss |
1.26 | PRILOSEC | acid reflux |
*drugs with at least 10 ratings
In the AskaPatient database, the patient
satisfaction rating score is 1 to 5, with 5 being "best" (the
medicine cured or helped a great deal) and 1 being "worst"
(medicine damaged more than it helped or the patient would not
recommend).
2019 Health Care News Highlights
In the United States:
- The phenomenon of
skyrocketing drug prices continued to occupy
national attention this year, with the Trump administration,
federal agencies, state and federal lawmakers, and presidential
candidates suggesting new rules to help make medicines more
affordable. Improving price transparency, allowing negotiation
of prices by Medicare, and allowing importation of drugs of
Canada under certain circumstances are some of the new rules
that have been proposed. Each of the proposals have faced strong
push-back from industry constituents.
-
CBD oil popularity
continued to surge, as did FDA interest in regulating the safety
of these products. In May, the FDA hosted an all-day public
hearing: "Scientific Data and Information about Products
Containing Cannabis or Cannabis-Derived Compounds." Since then,
the FDA has issued warning letters to various companies that
they said made unsubstantiated claims about CBD products sold
online.
- Healthcare
cybersecurity problems, including hospital
ransomware attacks, data theft and mishandling, and electronic
health record vulnerabilities have become increasingly common.
- Lawsuits against
pharmaceutical companies and
drug distributors
over the prescription opioid
epidemic were in full swing in 2019, with
settlements expected to be in the tens of billions of dollars.
- The FDA strengthened its warning to consumers to stop
using vaping products
containing THC amid more than 1,000 reports of
lung injuries—including some resulting in deaths—following the
use of vaping products. At the end of 2019, the minimum age for
purchase of the products was raised from 18 to 21.
https://www.fda.gov/tobacco-products/retail-sales-tobacco-products/selling-tobacco-products-retail-store
-
A total of 48 new drugs were
approved in 2019 for conditions including cystic
fibrosis, sickle cell anemia, peanut allergies, prostate cancer,
migraine, and more. A complete list of the new drugs is
available at the FDA web site: https://www.fda.gov/drugs/new-drugs-fda-cders-new-molecular-entities-and-new-therapeutic-biological-products/novel-drug-approvals-2019
Worldwide:
- Drug manufacturing quality
problems at facilities in China and India that
were exposed in 2018 continued in 2019. Many versions of
over-the-counter and prescription strength heartburn drug
ranitidine
(brand name Zantac) were recalled worldwide for possible
contamination with NDMA, the same contaminant found in the
Angiotensin II Receptor Blockers (ARB)
blood pressure drugs
valsartan, losartan, and irbesartan.
After running its own tests on samples of heartburn drug Zantac
and ranitidine, the FDA found an "unacceptable level" of NDMA
carcinogen, although not as high as levels found by Valisure,
the independent testing lab that first reported the contaminant.
https:///www.fda.gov/drugs/drug-safety-and-availability/fda-updates-and-press-announcements-ndma-zantac-ranitidine
For 2019 overview of ARB blood pressure drug recalls, see:
https://www.askapatient.com/news/generic-api-valsartan-worldwide-recall.asp
10 Most Popular AskaPatient Weekly Newsletter articles of 2019
A variety of health-related articles that we tweeted about or included in our newsletter caught our readers' attention in 2019. Here are the top ten:
1. While milk consumption in the
U.S. continues to decline, cheese consumption is up. Here is a
ranking of cheeses, from healthiest to least healthy, along with
recommended cheeses for different health needs.
https://www.telegram.com/entertainmentlife/20190903/from-feta-to-american-slices-ranking-of-cheeses-by-healthfulness
2. Swedish study identifies
the
scientific reason we gain weight as we get older.
https://www.sciencedaily.com/releases/2019/09/190909193211.htm
3. A type of blood pressure
lowering medication, called a calcium-channel blocker, may be
linked with an increased risk of a type of bowel condition
called
diverticulosis.
https://www.sciencedaily.com/releases/2019/07/190703121413.htm
4. Drug companies are
competing to develop a treatment for a disease that millions of
Americans may not know that they have.
https://www.cnbc.com/2018/12/21/the-35-billion-race-for-a-cure-for-a-liver-disease-that-affects-millions.html
5. Consumer Reports looked
into the quality of
bottled water and found a number of
roadblocks and red flags.
https://www.consumerreports.org/water-quality/looking-for-info-about-bottled-water-quality-good-luck/
6. Here are some popular web
sites for doctor ratings and reviews. We looked at ease of use,
cost, conflicts of interest, and caveats.
https://www.askapatient.com/news/doctor-ratings-sites
7.
Young Oklahoma man tears neck artery and has a stroke from
cracking his neck .
https://www.livescience.com/65399-neck-cracking-stroke.html
8. The 2019 - 2020 flu season is
here! Check out our article on the
eight approved 2019-2020 flu shots
and one nasal spray along with a summary of what is different
this year.
https://www.askapatient.com/news/flu-vaccines-for-2019-2020.asp
9. Study suggests that half of commonly taken
medications have a profoundly negative effect on the
gut
microbiome.
https://www.eurekalert.org/pub_releases/2019-10/sh-hoa101519.php
10. It happens unexpectedly: a
person long thought lost to the ravages of dementia, unable to
recall the events of their lives or even recognize those closest
to them, will suddenly wake up and exhibit surprisingly normal
behavior, only to pass away shortly thereafter.
https://www.sciencedaily.com/releases/2019/06/190628182305.htm